| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/20/2006 | WO2006007497A3 Prodrugs of mitotic kinesin inhibitors |
| 07/20/2006 | WO2006006021A3 Stabilized pharmaceutical compositions of preferably a statin |
| 07/20/2006 | WO2005123033A3 Fine particles of cilostazol and processes for production thereof |
| 07/20/2006 | WO2005121130A3 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 07/20/2006 | WO2005120487A3 Preparation for the prevention and treatment of stress conditions as well as functional and organic disorders of the nervous system and metabolic disorders |
| 07/20/2006 | WO2005115121A3 Adenylyl cyclase antibodies, compositions and uses thereof |
| 07/20/2006 | WO2005102392A3 Combinations for treating hiv infection |
| 07/20/2006 | WO2005096693A3 Cancer prognosis and/or diagnosis method |
| 07/20/2006 | WO2005095591A3 Novel genes from a biosynthesis gene cluster for aminoglycoside antibiotic synthesis and the thus obtained novel aminoglycoside antibiotics |
| 07/20/2006 | WO2005079344A3 Nicotine receptor agonists in stem cell and progenitor cell recruitment |
| 07/20/2006 | WO2005077111A3 Method and preparation for reducing skin hyperpigmentation |
| 07/20/2006 | WO2005072704A3 Method of treating acute rhinosinusitis |
| 07/20/2006 | WO2005070126A3 Methods and compositions for treating human diseases and wounds with ucp and fas inhibitors |
| 07/20/2006 | WO2005058363A3 Pharmaceutical composition of a sodium channel blocker and a selective serotonin uptake inhibitor |
| 07/20/2006 | WO2005053640A3 Azithromycin multiparticulate dosage forms by liquid-based processes |
| 07/20/2006 | WO2005051895A8 Organic compounds |
| 07/20/2006 | WO2005051297A3 Combination drug therapy to treat obesity |
| 07/20/2006 | WO2005042472A3 Hydroxypropyl amides for the treatment of alzheimer’s disease |
| 07/20/2006 | WO2005041886A3 Methods for generating or increasing revenues related to pain inhibitor commerce |
| 07/20/2006 | WO2004110368A3 Combination therapy for the treatment of hypertension |
| 07/20/2006 | WO2004108668A3 Alpha-7 neuronal nicotinic receptor ligands: compositions and methods of use |
| 07/20/2006 | WO2004080413A3 Uses and formulations for transdermal or transmucosal application of active agents |
| 07/20/2006 | WO2003101177A3 Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions |
| 07/20/2006 | US20060162014 Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules |
| 07/20/2006 | US20060162002 Drug screening; assaying for activators of the heat shock factor 1 (HSF-1) protein, which increases lifespan when overexpressed in an organism; antiaging agents |
| 07/20/2006 | US20060161020 2-(Benzoylamino-3-phenylpropylamino]acetamide derivatives prevent the formation of insoluble A beta |
| 07/20/2006 | US20060161018 Amino acid composition |
| 07/20/2006 | US20060161007 Oxazole and thiazole combinatorial libraries |
| 07/20/2006 | US20060161004 Quinoline derivatives for therapy and prophylaxis of chronic obstructive pulmonary disease (COPD), asthma, airway hyper-reactivity, cough, inflammatory diseases such as inflammatory bowel disease, psoriasis, fibrositis, osteoarthritis |
| 07/20/2006 | US20060160906 Polyamine analogs as therapeutic agents for ocular diseases |
| 07/20/2006 | US20060160905 Compositions and methods for inhibiting pain |
| 07/20/2006 | US20060160904 Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them |
| 07/20/2006 | US20060160903 Process for preparing benzhydrylthioacetamide |
| 07/20/2006 | US20060160902 Histone deacetylase inhibitors |
| 07/20/2006 | US20060160901 Method for selective targeting of apoptotic cells and small molecule ligands used thereof |
| 07/20/2006 | US20060160900 Intrathecal Gabapentin for Treatment of Pain |
| 07/20/2006 | US20060160899 Delivering gabapentin to the cerebrospinal fluid or brain using a pump system |
| 07/20/2006 | US20060160898 Administering orally/parentally octadecatrien-9,11,13-oic acid;normalize/improve impaired glucose tolerance and type 2 diabetes; preventand treat hyperglycemia and hyperinsulinemia; to attenuate the detrimental effects of high fat diets; minimize abdominal fat accumulation |
| 07/20/2006 | US20060160897 Topical Use of Valproic Acid for the Prevention or Treatment of Skin Disorders |
| 07/20/2006 | US20060160896 Therapeutic treatment |
| 07/20/2006 | US20060160895 Anti-cancer agents |
| 07/20/2006 | US20060160894 Benzamides as ppar modulators |
| 07/20/2006 | US20060160892 Methods for treating hyperactive gastric motility |
| 07/20/2006 | US20060160891 Process for producing powdered compositions containing highly unsaturated fatty acid esters of ascorbic acid and powdered compositions containing the esters |
| 07/20/2006 | US20060160890 Triterpenoid derivatives |
| 07/20/2006 | US20060160889 4-benzyl-2-phenylchroman skeleton with hydroxyl substitutions compounds; estrogen beta -receptors (ER beta ) modulator; hormone replacement therapy; osteoporosis, postmenopause; side effect reduction |
| 07/20/2006 | US20060160888 Room-temperature stable dronabinol formulations |
| 07/20/2006 | US20060160887 Medicinal composition |
| 07/20/2006 | US20060160886 Chemical compounds |
| 07/20/2006 | US20060160885 Chemical compounds |
| 07/20/2006 | US20060160884 N-{[4-(but-2-ynyloxy)phenyl]sulfonyl}-1-(2-fluorobenzyl)-5-methoxy-2-methyltryptophan; for treatment of rheumatoid arthritis, juvenile rheumatoid arthritis, ulcerative colitis, or Crohn's disease |
| 07/20/2006 | US20060160883 Regulation of immune system action in mammals through use of a multi-tiered model of immune system function |
| 07/20/2006 | US20060160882 Indoline derivatives |
| 07/20/2006 | US20060160881 Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan |
| 07/20/2006 | US20060160880 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI |
| 07/20/2006 | US20060160879 Indoles useful in the treatment of inflammation |
| 07/20/2006 | US20060160878 For therapy of central nervous system disorders related to or affected by the 5-HT6 receptor |
| 07/20/2006 | US20060160877 2-Heteroaryl carboxamides |
| 07/20/2006 | US20060160876 Indole derivatives |
| 07/20/2006 | US20060160875 Matrix metalloproteinase inhibitors |
| 07/20/2006 | US20060160874 anticarcinogenic agent; antitumor; antiproliferative; 1-ethyl 5-methyl 3-[(3,5-difluorobenzoyl)amino]-1H-thieno[3,2-c]pyrazole-1,5-dicarboxylate; N-benzyl-3-{[4-(4-ethylpiperazin-1-yl)benzoyl]amino}-1H-thieno[3,2-c]pyrazole-5-carboxamide; can treat neurodegenerative disorders, angiogenesis and metastasis |
| 07/20/2006 | US20060160873 Substituted thiophenes; potent inhibitory properties on the sodium/proton exchanger of subtype 3; respiratory disorders, acute/chronic renal diseases, intestinal function disorders, disorders of the central nervous system; 3N-(5-Fluoro-2-benzimidazolyl)-4-methyl-3-thienylamine hydrochloride |
| 07/20/2006 | US20060160872 Substituted benzimidazoles and derivatives thereof and compositions containing them for the treatment of acute, inflammatory and neuropathic pain; 5-(7-bromo-5-(trifluoromethyl)-1H-benzo[d]imidazol-2-ylamino)naphthalen-2-ol |
| 07/20/2006 | US20060160871 Stable non-crystalline formulation comprising losartan |
| 07/20/2006 | US20060160870 3-phenylpropionic acid derivatives |
| 07/20/2006 | US20060160869 Ubiquitin ligase inhibitors |
| 07/20/2006 | US20060160868 3-Phenylpropionic acid derivatives |
| 07/20/2006 | US20060160867 Methods for modulating PPAR biological activity for the treatment of diseases caused by mutations in the CFTR gene |
| 07/20/2006 | US20060160866 Anti-coronavirus compounds |
| 07/20/2006 | US20060160865 Pyridinyl carbamates |
| 07/20/2006 | US20060160864 Acrylamide derivative, process for producing the same, and use |
| 07/20/2006 | US20060160863 Polymorphic and amorphous forms of 2-{3-[(E)-2-(4,6-dimethyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-N-(4-hydroxy-but-2-ynyl)benzamide |
| 07/20/2006 | US20060160862 Caspase inhibitors and uses thereof |
| 07/20/2006 | US20060160861 Novel nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors |
| 07/20/2006 | US20060160860 Synthesis of polyamine compounds |
| 07/20/2006 | US20060160859 Method for treating HIV infection through co-administration of tipranavir and GW873140 |
| 07/20/2006 | US20060160858 Administering N-Cyclopropyl-2-{3-[(E)-2-(4-methyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-benzamide for treating ophthalmic disease which is age related macular degeneration, diabetic retinopathy, or neovascular glaucoma |
| 07/20/2006 | US20060160857 5-(Pyridin-3-ylamino)-thiazole-4-carboxylic acid (6-methyl-pyridin-2-yl)-amide; metabotropic glutamate receptor antagonists; neurological disorders such as anxiety and chronic or acute pain |
| 07/20/2006 | US20060160856 Diarylurea derivatives and their use as chloride channel blockers |
| 07/20/2006 | US20060160855 [5-(1-Ethyl-piperidin-4-ylamino)-1H-indol-2-yl]-morpholin-4-yl-methanone; useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors; treatment of obesity or eating disorders in human being or animals |
| 07/20/2006 | US20060160854 Methods for the treatment of cachexia |
| 07/20/2006 | US20060160853 2-[(4-Benzyl)-1-piperidinyl)methyl]benzimidazole-5-ol derivatives as nr2b receptor antagonists |
| 07/20/2006 | US20060160852 Donepezil; ethylcellulose high molecular weight basic water-insoluble polymer; methacrylic acid-ethyl acrylate high molecular weight acidic enteric polymer; sustained-release base prevent, inhibit degradation |
| 07/20/2006 | US20060160851 Substituted piperidine carbamates |
| 07/20/2006 | US20060160850 antagonists; regulation of appetite; obesity; smoking cessationp; [1-Benzyl-6-(2-methyl-2H-tetrazol-5-yl)-1,2,3,4-tetrahydroquinolin-3-yl]-carbamic acid cyclohexyl ester |
| 07/20/2006 | US20060160849 Pharmaceutical compositions containing sulphonic acid derivatives |
| 07/20/2006 | US20060160848 Method of controlling damage mediated by alpha, beta-unsaturated aldehydes |
| 07/20/2006 | US20060160846 Quinoline derivatives |
| 07/20/2006 | US20060160845 Aminophenyl derivatives as selective androgen receptor modulators |
| 07/20/2006 | US20060160844 3-(2-Benzyl-2-hydroxy-3-phenyl-propylidene)-8,8-dimethyl-8-azonia-bicyclo[3.2.1]octane iodide; muscle relaxants, respiratory system disorders; asthma, bronchitis, chronic obstructive lung disease, chronic bronchitis, chronic respiratory obstruction, pulmonary fibrosis, pulmonary fibrosis |
| 07/20/2006 | US20060160843 Method for treating neuropathic pain and associated syndromes |
| 07/20/2006 | US20060160842 in brain; (2,5-difluorodifluorophenyl)-N-methyl-N-((1-propylbenzimidazol-2-yl)methyl)carboxamide; anxiolitic and antidepressant; finding and altering the signal-transducing activity of gamma aminobutyric acid (GABA) receptors; detectably-labeled antagonist/agonist of GABAR |
| 07/20/2006 | US20060160841 Crystallization via high-shear transformation |
| 07/20/2006 | US20060160840 Tetrahydroisoquinolines as factor Xa inhibitors |
| 07/20/2006 | US20060160839 2-[2-(4-methoxypyridin-2-yl)ethyl]-3H-imidazo[4,5-b]quinoline; inducible nitric oxide synthase inhibitor; antiinflammatory agent; acute and chronic inflammatory diseases of peripheral organs and CNS: sepsis, grafting, rheumatoid arthritis, eczema, diabetes, Alzheimer's, Parkinson's, and Crohn's diseases |
| 07/20/2006 | US20060160838 Topically active FK520 and FK506 analogs; calcineurin inhibitorse useful in the treatment of immunoregulatory and respiratory disorders; lung or heart transplantation; antiinflammatory agents; bronchitis; asthma; immunosuppressants; autoimmune diseases eosinophil-related diseases |
| 07/20/2006 | US20060160837 Rapamycin compounds in the treatment of neurofibromatosis type 1 |
| 07/20/2006 | US20060160836 Estrogen receptor structure |
| 07/20/2006 | US20060160835 Methods and compositions for treatment of central nervous system disorders |
| 07/20/2006 | US20060160834 Combination therapy for the treatment of hypertension |